Bioinformatic analysis of non-VP1 capsid protein of coxsackievirus A6

Abstract

This study bioinformatically analyzed the non-VP1 capsid proteins (VP2-VP4) of Coxasckievirus A6 (CVA6), with an attempt to predict their basic physicochemical properties, structural/functional features and linear B cell eiptopes. The online tools SubLoc, TargetP and the others from ExPASy Bioinformatics Resource Portal, and SWISS-MODEL (an online protein structure modeling server), were utilized to analyze the amino acid (AA) sequences of VP2-VP4 proteins of CVA6. Our results showed that the VP proteins of CVA6 were all of hydrophilic nature, contained phosphorylation and glycosylation sites and harbored no signal peptide sequences and acetylation sites. Except VP3, the other proteins did not have transmembrane helix structure and nuclear localization signal sequences. Random coils were the major conformation of the secondary structure of the capsid proteins. Analysis of the linear B cell epitopes by employing Bepipred showed that the average antigenic indices (AI) of individual VP proteins were all greater than 0 and the average AI of VP4 was substantially higher than that of VP2 and VP3. The VP proteins all contained a number of potential B cell epitopes and some eiptopes were located at the internal side of the viral capsid or were buried. We successfully predicted the fundamental physicochemical properties, structural/functional features and the linear B cell eiptopes and found that different VP proteins share some common features and each has its unique attributes. These findings will help us understand the pathogenicity of CVA6 and develop related vaccines and immunodiagnostic reagents.

Keywords

Coxsackievirus A6 (CVA6) / capsid proteins / bioinformatics / physicochemical properties / structural and functional domains / linear B cell eiptopes

References

[1] BianL, WangY, YaoX, et al.. Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide. Expert Rev Anti-infect Ther, 2015, 13(9): 1061-1071

[2] YangF, YuanJ, WangX, et al.. Severe hand, foot, and mouth disease and coxsackievirus A6-Shenzhen, China. Clin Infect Dis, 2014, 59(10): 1504-1505

[3] HogleJM, ChowM, FilmanDJ. Three-dimensional structure of poliovirus at 2.9 A resolution. Science, 1985, 229(4720): 1358-1365

[4] HuangSW, WangYF, YuCK, et al.. Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement. Virology, 2012, 422(1): 132-143

[5] ObersteMS, MaherK, KilpatrickDR, et al.. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol, 1999, 73(3): 1941-1948

[6] XuL, HeD, YangL, et al.. A broadly cross-protective vaccine presenting the neighboring epitopes within the VP1 GH loop and VP2 EF loop of enterovirus 71. Scientific Rep, 2015, 5: 12973

[7] KimDS, ParkJH, KimJY, et al.. A mechanism of immunoreceptor tyrosine-based activation motif (ITAM)-like sequences in the capsid protein VP2 in viral growth and pathogenesis of Coxsackievirus B3. Virus Genes, 2012, 44(2): 176-182

[8] XuL, HeD, LiZ, et al.. Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop. Theranostics, 2014, 4(5): 498-513

[9] KienerTK, JiaQ, MengT, et al.. A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein. PLoS Negl Trop Dis, 2014, 8(5): e2895

[10] ZhaoM, BaiY, LiuW, et al.. Immunization of N terminus of enterovirus 71 VP4 elicits cross-protective antibody responses. BMC Microbiol, 2013, 13: 287

[11] IshikoH, ShimadaY, YonahaM, et al.. Molecular diagnosis of human enteroviruses by phylogeny-based classification by use of the VP4 sequence. J Infect Dis, 2002, 185(6): 744-754

[12] LiuHB, YangGF, OuWL, et al.. Bioinformatic analysis of VP1 capsid protein of Coxsackievirus A6. Chin J Immunol (Chinese), 2016, 32(4): 536-541

[13] HaolongC, DuN, HongchaoT, et al.. Enterovirus 71 VP1 activates calmodulin-dependent protein kinase II and results in the rearrangement of vimentin in human astrocyte cells. PLoS One, 2013, 8(9): e73900

[14] RamsinghAI, CollinsDN. A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence. J Virol, 1995, 69(11): 7278-7281

[15] Soria-GuerraRE, Nieto-GomezR, Govea-AlonsoDO, et al.. An overview of bioinformatics tools for epitope prediction: implications on vaccine development. J Biomed Inform, 2015, 53: 405-414

[16] RoivainenM, PiirainenL, RysäT, et al.. An immunodominant N-terminal region of VP1 protein of poliovirion that is buried in crystal structure can be exposed in solution. Virology, 1993, 195(2): 762-765

[17] GreveJM, ForteCP, MarlorCW, et al.. Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1. J Virol, 1991, 65(11): 6015-6023

[18] KatpallyU, FuTM, FreedDC, et al.. Antibodies to the buried N terminus of rhinovirus VP4 exhibit cross-serotypic neutralization. J Virol, 2009, 83(14): 7040-7048

[19] SongYB, YuN, HeSJ, et al.. Gene cloning and immunogenicity analysis of the structural proteins VP1-VP4 of enterovirus 71. Nan Fang Yi Ke Da Xue Xue Bao (Chinese), 2011, 31(11): 1846-1850

RIGHTS & PERMISSIONS

Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg